Results 131 to 140 of about 54,178 (260)
British Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 1957-1976, July 2026.Carbamazepine is licensed in the United Kingdom for the treatment of epilepsy, bipolar disorder and trigeminal neuralgia. The related compounds oxcarbazepine and eslicarbazepine are licensed for the treatment of epilepsy. These drugs can cause immune‐mediated hypersensitivity reactions, which typically affect the skin, and can be of variable severity ...
Lucy Galloway +24 more
wiley +1 more source
, 1931 Neuralgia may be defined as a functional disturbance of a nerve with paroxysmal pain. No appearance of the disease can be detected. The pain that is present must be regarded as a symptom of an irritation not located, - it is not the diseaseitself.
Chudacoff, Sidney
core
Postherpetic Neuralgia: Mechanisms, Risk Factors, and Stratified Management—A Narrative Review
CNS Neuroscience &Therapeutics, Volume 32, Issue 7, July 2026.The incidence of PHN is increasing, posing a substantial public health burden. Its pathogenesis involves VZV reactivation, peripheral and central sensitization, and genetic susceptibility, with key risk factors including older age, severe acute pain, extensive rash, immunocompromise, comorbidities, and delayed treatment.
Fei Tang, Fukun Zhao
wiley +1 more source
, 2002 Objetivos: Avaliar toda a informacao clinica disponivel sobre neuralgia e gustacao, incluidas ou nao sob o titulo de neuralgia gustatoria, descritas na literatura cientifica.
Gomes, Eugenio Valente [UNIFESP]
core
TrkA abundance is increased in cutaneous nerves in bortezomib‐induced neuropathy
Brain Pathology, Volume 36, Issue 4, July 2026.Cutaneous nerves in bortezomib‐induced peripheral neuropathy (BIPN) show reduced nerve fiber density, increased TrkA expression, and enhanced dermal angiogenesis, highlighting a pathological switch in NGF/TrkA signaling that may contribute to nerve damage and pain. Abstract Tropomyosin receptor kinase A (TrkA), a high‐affinity receptor for nerve growth
Yuying Jin +14 more
wiley +1 more source
Clinical and Translational Science, Volume 19, Issue 7, July 2026.ABSTRACT Ibuprofen is the most commonly used NSAID; however, its short biological half‐life, reflected in the short duration of pain relief, limits the comfortableness of its usage. This study evaluated the pharmacokinetic properties of a newly developed biphasic ibuprofen 400 mg immediate‐release/sustained‐release (IR/SR) modified‐release tablets ...
Ludmila Kvapilová +6 more
wiley +1 more source
, 2015 Background: When assessing pain in clinical practice, clinicians often label pain as mild, moderate, and severe. However, these categories are not distinctly defined, and are often used arbitrarily.
Zakrzewska, JM, Brailo, V
core +1 more source
Odontogenic atypical trigeminal neuralgia
, 2020 The typical clinical presentation of odontogenic atypical trigeminal neuralgia involves pain in a tooth in the absence of any sign of pathology. The paper is concerned with the problem of the etiology, pathogenesis, clinical picture, principles diagnosis,
core +1 more source
Reappraisal of glossopharyngeal neuralgia
, 2018 Glossopharyngeal neuralgia is a rare disease characterized by severe paroxysmal attacks of pain in the distribution of the 9th cranial nerve. Glossopharyngeal neuralgia primarily can be caused by compression of the glossopharyngeal nerve, but in some ...
Osama Ali Altaleb +3 more
core +1 more source
Drug and Alcohol Review, Volume 45, Issue 5, July 2026.ABSTRACT Introduction Gabapentin is widely prescribed off‐label to treat pain. However, there are concerns about the proliferation of medical and non‐medical use, and the potential increased risk of overdose death associated with concurrent opioid use.
Evelyne Marie Piret +7 more
wiley +1 more source